Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic solution) in the COPERNICUS study, which is led by Regeneron, the first of two Phase 3 studies in patients with mac…
Category: News
Regeneron And Bayer Report Positive Results For VEGF Trap-Eye In Phase 3 Study In Central Retinal Vein Occlusion (CRVO) And In Phase 2 Study In Diabetic Macular Edema (DME)
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic solution) in the COPERNICUS study, which is led by Regeneron, the first of two Phase 3 studies in patients with mac…
Shopping for Electronic Medical Records
Technology Spotlight
PERGLA Measures Changes After Eye-Pressure Surgery
Pattern electroretinogram optimized for glaucoma screening (PERGLA) appears useful in measuring the reversal of retinal ganglion cell (RGC) dysfunction following surgical treatment of intraocular pressure, according to research published in the Decembe…
PERGLA Measures Changes After Eye-Pressure Surgery
Pattern electroretinogram optimized for glaucoma screening (PERGLA) appears useful in measuring the reversal of retinal ganglion cell (RGC) dysfunction following surgical treatment of intraocular pressure, according to research published in the Decembe…
PERGLA Measures Changes After Eye-Pressure Surgery
Pattern electroretinogram optimized for glaucoma screening (PERGLA) appears useful in measuring the reversal of retinal ganglion cell (RGC) dysfunction following surgical treatment of intraocular pressure, according to research published in the Decembe…
What Caught the Eye of Ophthalmologists in 2010?
Find out ophthalmologists’ top 10 most-read articles on Medscape this year. Medscape Ophthalmology
Neuroprotective Agents in Glaucoma Therapy: Recent Developments and Future Directions
How do neuroprotective agents work in glaucoma patients, and which are the most promising? Expert Review of Ophthalmology
Interim guidance for management of retinal vein occlusion 2010
The document aims to provide updated recommendations on the management of retinal vein occlusion (RVO) in the light of recent developments in both diagnostic tools and treatment options that supersede those in the previous RVO guidelines. It has also r…
MCV Foundation To Receive $500,000 Research Donation
A new partnership between Richmond Eye & Ear Healthcare Alliance (REEHA) and the Medical College of Virginia Foundation will provide over $500,000 for the VCU Health System’s Department of Orthopaedics through December 2014…
Research and Markets: Cataract Surgery – Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/4f2453/cataract_surgery) has announced the addition of GlobalData’s new report “Cataract Surgery – Global Pipeline Analysis, Opportunity Assessment and Market For…
Outreach Screening for Diabetic Retinopathy May Be Effective
Outreach screening for DR is an effective alternative to on-site specialist examination and could increase screening of high-risk patients in remote and resource-poor settings. Medscape Medical News
Preoperative Pupil Size Does Not Affect Quality of Vision After LASIK
Although large pupil size is viewed by some ophthalmologists as a relative contraindication to undergoing LASIK, preoperative pupil size does not affect quality of vision after wavefront-guided LASIK, two researchers from Stanford University in Califor…
NextGen Healthcare announces partnership with Wills Eye for meaningful use
NextGen Healthcare Information Systems, a wholly owned subsidiary of Quality Systems, and leading provider of healthcare information systems and connectivity solutions, today announced an agreement with Wills Eye Health System to deploy NextGen® Ambul…
Inspire Announces Launch Of DIQUASTM By Santen In Japan
Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced that DIQUASTM Ophthalmic Solution 3% (diquafosol tetrasodium) received pricing approval and was launched for sale today in Japan by its partner, Santen Pharmaceutical Co., Ltd. Inspire will receive…
American Academy Of Ophthalmology Joins Forces With Cloud Nine Development, LLC On The Eye Handbook IPhone Application
The American Academy of Ophthalmology (Academy) has collaborated with Cloud Nine Development, LLC, to enhance its free iPhone application, the Eye Handbook. The application, created for ophthalmologists by ophthalmologists, offers ophthalmic calculator…
Alcon And Novartis Agree To Merger Terms
Alcon, Inc. (NYSE: ACL) announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not currently own. Under the …
Antibiotic Resistance Observed In Some Patients Undergoing Intravitreal Injections
Patients who underwent intravitreal injections for choroidal neovascularization showed resistance to third- and fourth-generation fluoroquinolones, especially those infected with coagulase-negative staphylococcus, a study said.
Alcon And Novartis Agree To Merger Terms
Alcon, Inc. (NYSE: ACL) announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not currently own. Under the …
Alcon And Novartis Agree To Merger Terms
Alcon, Inc. (NYSE: ACL) announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not currently own. Under the …